Brief: Carna Biosciences and Sumitomo Dainippon Pharma sign agreement on joint research, development, and commercialization of kinase inhibitors
27/03/2018 08:47
March 27 (Reuters) - Carna Biosciences Inc 4572.T
* Says it and Sumitomo Dainippon Pharma Co Ltd 4506.T ,
signed
an agreement on joint research with the aim of discovering novel
kinase inhibitors for psychiatric and neurological disorders, as
well as on the subsequent development and commercialization of
such therapeutic agent
Source text in Japanese:https://goo.gl/UpXnjP
Further company coverage: 4572.T 4506.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))